|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Antiangiogenic Versus Cytotoxic
Therapeutic Approaches to Human Pancreas Cancer: An Experimental
Study with aa Vascular Endothelial Growth Factor Receptor-2 Tyrosine
Kinase Inhibitor and Gemcitabine Eur J Pharmacol. 2004 Sep 13;498(1-3):9-18. PMID: 15363970
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |